HUTCHMED China Ltd (HCM) - Total Assets

Latest as of December 2025: GBX1.75 Billion GBX ≈ $213.30K USD

Based on the latest financial reports, HUTCHMED China Ltd (HCM) holds total assets worth GBX1.75 Billion GBX (≈ $213.30K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

HUTCHMED China Ltd - Total Assets Trend (2005–2025)

This chart illustrates how HUTCHMED China Ltd's total assets have evolved over time, based on quarterly financial data. Also see HUTCHMED China Ltd market capitalisation for the company's overall valuation and market capitalisation.

HUTCHMED China Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

HUTCHMED China Ltd's total assets of GBX1.75 Billion consist of 89.4% current assets and 10.6% non-current assets. Review HUTCHMED China Ltd (HCM) total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	4.1%
Accounts Receivable	GBX147.63 Million	8.4%
Inventory	GBX41.07 Million	2.4%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX8.93 Million	0.5%
Goodwill	GBX3.11 Million	0.2%

Asset Composition Trend (2005–2025)

This chart illustrates how HUTCHMED China Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See HCM stock price and chart for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: HUTCHMED China Ltd's current assets represent 89.4% of total assets in 2025, an increase from 47.7% in 2005.
Cash Position: Cash and equivalents constituted 4.1% of total assets in 2025, down from 8.9% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 19.0% in 2005.
Asset Diversification: The largest asset category is accounts receivable at 8.4% of total assets.

HUTCHMED China Ltd Competitors by Total Assets

Key competitors of HUTCHMED China Ltd based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

HUTCHMED China Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.96	2.83	2.63
Quick Ratio	4.83	2.70	2.53
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX1.25 Billion	GBX689.99 Million	GBX307.71 Million

HUTCHMED China Ltd - Advanced Valuation Insights

This section examines the relationship between HUTCHMED China Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.90
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	37.4%
Total Assets	GBX1.75 Billion
Market Capitalization	$21.25 Million USD

Valuation Analysis

Below Book Valuation: The market values HUTCHMED China Ltd's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: HUTCHMED China Ltd's assets grew by 37.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for HUTCHMED China Ltd (2005–2025)

The table below shows the annual total assets of HUTCHMED China Ltd from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	GBX1.75 Billion ≈ $213.01K	+37.40%
2024-12-31	GBX1.27 Billion ≈ $155.03K	-0.44%
2023-12-31	GBX1.28 Billion ≈ $155.71K	+24.32%
2022-12-31	GBX1.03 Billion ≈ $125.25K	-25.00%
2021-12-31	GBX1.37 Billion ≈ $167.01K	+89.56%
2020-12-31	GBX724.12 Million ≈ $88.10K	+55.68%
2019-12-31	GBX465.12 Million ≈ $56.59K	-12.59%
2018-12-31	GBX532.12 Million ≈ $64.74K	-11.01%
2017-12-31	GBX597.93 Million ≈ $72.75K	+74.61%
2016-12-31	GBX342.44 Million ≈ $41.66K	+49.05%
2015-12-31	GBX229.75 Million ≈ $27.95K	+4.94%
2014-12-31	GBX218.94 Million ≈ $26.64K	+17.92%
2013-12-31	GBX185.67 Million ≈ $22.59K	-11.36%
2012-12-31	GBX209.47 Million ≈ $25.49K	+7.54%
2011-12-31	GBX194.77 Million ≈ $23.70K	+21.79%
2010-12-31	GBX159.93 Million ≈ $19.46K	+25.18%
2009-12-31	GBX127.75 Million ≈ $15.54K	+8.31%
2008-12-31	GBX117.96 Million ≈ $14.35K	-7.53%
2007-12-31	GBX127.56 Million ≈ $15.52K	-4.12%
2006-12-31	GBX133.04 Million ≈ $16.19K	+111.58%
2005-12-31	GBX62.88 Million ≈ $7.65K	--

About HUTCHMED China Ltd

LSE:HCM UK Drug Manufacturers - Specialty & Generic

Market Cap

$21.25 Million

GBX174.68 Billion GBX

Market Cap Rank

#25001 Global

#240 in UK

Share Price

GBX201.00

Change (1 day)

+1.01%

52-Week Range

GBX156.00 - GBX264.00

All Time High

GBX624.00